APA (7th ed.) Citation

Hu, R., Wei, W., Mian, A., Gonter‐Aubin, K., Kabel, C., Mato, A., . . . Hill, B. T. (2022). Treatment outcomes with purine nucleoside analog alone or with rituximab for hairy cell leukemia at first relapse. European Journal of Haematology, 108(5), 379. https://doi.org/10.1111/ejh.13744

Chicago Style (17th ed.) Citation

Hu, Rachel, et al. "Treatment Outcomes with Purine Nucleoside Analog Alone or with Rituximab for Hairy Cell Leukemia at First Relapse." European Journal of Haematology 108, no. 5 (2022): 379. https://doi.org/10.1111/ejh.13744.

MLA (9th ed.) Citation

Hu, Rachel, et al. "Treatment Outcomes with Purine Nucleoside Analog Alone or with Rituximab for Hairy Cell Leukemia at First Relapse." European Journal of Haematology, vol. 108, no. 5, 2022, p. 379, https://doi.org/10.1111/ejh.13744.